Biblio

Export 12 results:
Author Title [ Type(Desc)] Year
Filters: Author is Stern, Yaakov  [Clear All Filters]
Journal Article
B. Dubois, Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. Luis, Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., Cappa, S., Crutch, S., Engelborghs, S., Frisoni, G. B., Fox, N. C., Galasko, D., Habert, M. - O., Jicha, G. A., Nordberg, A., Pasquier, F., Rabinovici, G., Robert, P., Rowe, C., Salloway, S., Sarazin, M., Epelbaum, S., de Souza, L. C., Vellas, B., Visser, P. J., Schneider, L., Stern, Y., Scheltens, P., and Cummings, J. L., Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria., Lancet Neurol, vol. 13, no. 6, pp. 614-29, 2014.
D. P. Devanand, Lentz, C., Chunga, R. E., Ciarleglio, A., Scodes, J. M., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Bell, K., and Pelton, G. H., Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment., J Alzheimers Dis, vol. 60, no. 4, pp. 1525-1531, 2017.
Y. Stern, Cognitive reserve in ageing and Alzheimer's disease., Lancet Neurol, vol. 11, no. 11, pp. 1006-12, 2012.
C. W. Zhu, Gu, Y., Kociolek, A. J., Fernandez, K. K., Cosentino, S., and Stern, Y., Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 457-466, 2023.
L. B. Zahodne, Schupf, N., Brickman, A. M., Mayeux, R., Wall, M. M., Stern, Y., and Manly, J. J., Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups., J Alzheimers Dis, vol. 52, no. 3, pp. 1013-20, 2016.
C. W. Zhu, Cosentino, S., Ornstein, K. A., Gu, Y., Andrews, H., and Stern, Y., Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures., J Alzheimers Dis, vol. 57, no. 1, pp. 305-315, 2017.
D. P. Devanand, Liu, X., Chunga, R. E., Cohen, H., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Choi, J., and Pelton, G. H., Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment., J Alzheimers Dis, vol. 75, no. 3, pp. 845-854, 2020.
C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study., J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
C. W. Zhu, Gu, Y., Cosentino, S., Kociolek, A. J., Hernandez, M., and Stern, Y., Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project., J Alzheimers Dis, vol. 96, no. 1, pp. 359-368, 2023.
R. A. Sperling, Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 280-92, 2011.
M. J. Lan, R Ogden, T., Kumar, D., Stern, Y., Parsey, R. V., Pelton, G. H., Rubin-Falcone, H., Pradhaban, G., Zanderigo, F., Miller, J. M., J Mann, J., and Devanand, D. P., Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia., J Alzheimers Dis, vol. 60, no. 3, pp. 939-947, 2017.
E. Stallard, Kociolek, A., Jin, Z., Ryu, H., Lee, S., Cosentino, S., Zhu, C., Gu, Y., Fernandez, K., Hernandez, M., Kinosian, B., and Stern, Y., Validation of a Multivariate Prediction Model of the Clinical Progression of Alzheimer's Disease in a Community-Dwelling Multiethnic Cohort., J Alzheimers Dis, vol. 95, no. 1, pp. 93-117, 2023.